Abstract P3-11-04: Endoxifen Downregulates AKT Phosphorylation Through Protein Kinase C Beta 1 in ER+/HER2- Breast Cancer
Swaathi Jayaraman(Johns Hopkins University), Matthew P. Goetz(Mayo Clinic), Joel M. Reid(Children's Hospital of Philadelphia), John R. Hawse(Mayo Clinic in Arizona), Santosh Renuse(AstraZeneca (United States)), Xiaojia Tang(Mayo Clinic), James N. Ingle(Mayo Clinic), Krishna R. Kalari(Mayo Clinic in Florida), Elizabeth S. Bruinsma(Mayo Clinic in Arizona), Xinyan Wu(Qingdao University), Matthew J. Schellenberg(Mayo Clinic), Mary J. Kuffel(Mayo Clinic in Arizona), Akhilesh Pandey(Mayo Clinic)
Cited by 0
Related Papers
A draft map of the human proteome
|Nature|2014|2.3k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|1.6k
Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls
|Scientific Reports|2016|973